4th Annual Cytokines and Inflammation - Call for Abstracts
The 4th annual conference on Cytokines and Inflammation will cover many important fundamental aspects of the role of cytokine and inflammation as related to drug discovery and development, including current drugs, progress of potential drugs in pre-clinical and clinical trials, and new research and developments in this field. We hope to achieve these goals by bringing together conceptual innovators from all active parties who certainly include scientists, industry leaders, entrepreneurs, and regulators.
In addition to the Keynote presentation by Dr. Joost Oppenheim from the NIH, there are 23 excellent speakers and more confirming everyday. Presenters from organizations such as NCI, Amgen, Regeneron, Aventis, FDA, Novartis, Xoma, Roche, Isis, Genentech, Genzyme Corp, Johnson & Johnson, Neopharm, Celgene, Serono, ZymoGenetics, Biogen Idec, and The Scripps Research Institute.
The 4th annual conference on Cytokines and Inflammation will take place at the San Diego Marriott in La Jolla, California on Monday and Tuesday, January 30 and 31, 2006. Come enjoy San Diego and all the delights it has to offer.
Please bring this conference to the attention of your colleagues who may benefit from attending. Please register early and submit an abstract.
ABSTRACT SUBMISSION DEADLINE: December 30, 2005
A few abstracts will be selected for oral presentation.
Early Registration Deadline: November 30, 2005
Confirmed Speakers:
Simon Blake
Centacor, (J&J)
Lawrence Blatt
Vice President
InterMune
Hal Blumberg
Inflammation
Amgen, Inc.
Chris Clegg
Associate Director
ZymoGenetics
Rosanne Crooke
Program Leader, Cardiovascular Group
Isis Pharmaceuticals
David Croteau
Dir, Clinical & Medical Affairs
NeoPharm
Raymond Donnelly
Div of Therapeutic Proteins
CBER, FDA
Scott Durum
Principal Investigator
NCI, FCRF, NIH
Alan Jackson
Novartis Research Institute
Andy Chan
Genentech, Inc.
William Farrar
Deputy, Lab of Molecular Immunoregulation
NCI, FCRF, NIH
Robert Gundel
VP, Preclinical Research
XOMA
Sam Hwang
NCI, NIH
Margaret Karow
Vice President
Regeneron
Steven Ledbetter
VP, Renal Diseases
Genzyme Corporation
Alan Lewis
President
Celgene San Diego
Joost Oppeheim
Chief, Lab of Molecular Immunoregulation
NCI, FCRF, NIH
John Carulli
Principal Scientist
Biogen Idec
Garth Ringheim
Principal Scientist, Immunology
Aventis Pharmaceuticals
Michael Pollard
The Scripps Research Institute
Nora Sarvetnick
Scripps Research Inst
Thomas Schall
President & CEO
ChemoCentryx
Robert Strieter
Prof and Chief, Div of Pulmonary & Critical Care Medicine
UCLA
Julian Symons
Head, HCV Biology
Roche Palo Alto
Ji Ming Wang
Head, Chemoattractant Receptor & Signal Group
NCI, FCRF, NIH
Tamas Oravecz
Senior Director, Immunology and Hematology
Lexicon Genetics, Inc
